1. Repository of OAI
Ελληνικά   English  

Browsing by Author Liberopoulos, E. N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 34 to 53 of 117 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Early statin therapy in patients with acute coronary syndromeLiberopoulos, E. N.; Daskalopoulou, S. S.; Mikhailidis, D. P.24-Nov-2015-
Effect of apolipoprotein E polymorphism on serum uric acid levels in healthy subjectsLiberopoulos, E. N.; Miltiadous, G. A.; Athyros, V. G.; Ganotakis, M.; Cariolou, M.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrateChristidis, D. S.; Liberopoulos, E. N.; Kakafika, A. I.; Miltiadous, G. A.; Cariolou, M.; Ganotakis, E. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot studySpirou, A.; Rizos, E.; Liberopoulos, E. N.; Kolaitis, N.; Achimastos, A.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
The effect of cholesterol-lowering treatment on renal functionLiberopoulos, E. N.; Mikhailidis, D. P.; Athyros, V. G.; Elisaf, M. S.24-Nov-2015-
Effect of Ezetimibe on Markers of Oxidative Stress in Patients with HypercholesterolemiaKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised studyAthyros, V. G.; Mikhailidis, D. P.; Didangelos, T. P.; Giouleme, O. I.; Liberopoulos, E. N.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Burroughs, A. K.; Elisaf, M. S.24-Nov-2015-
Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed DyslipidaemiaFlorentin, M.; Tselepis, A. D.; Elisaf, M. S.; Rizos, C. V.; Mikhailidis, D. P.; Liberopoulos, E. N.24-Nov-2015-
The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndromeFilippatos, T. D.; Gazi, I. F.; Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Tselepis, A. D.; Kiortsis, D. N.24-Nov-2015-
Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli studyFilippatos, T. D.; Kiortsis, D. N.; Liberopoulos, E. N.; Georgoula, M.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatinChristidis, D. S.; Liberopoulos, E. N.; Kakafika, A. I.; Miltiadous, G. A.; Liamis, G. L.; Kakaidi, B.; Tselepis, A. D.; Cariolou, M. A.; Elisaf, M. S.24-Nov-2015-
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot studyFlorentin, M.; Liberopoulos, E. N.; Filippatos, T. D.; Kostara, C.; Tselepis, A.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015-
Effect of Rosuvastatin Monotherapy and in Combination With Fenofibrate or Omega-3 Fatty Acids on Serum Vitamin D LevelsMakariou, S. E.; Liberopoulos, E. N.; Agouridis, A. P.; Challa, A.; Elisaf, M. S.24-Nov-2015-
The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemiaFlorentin, M.; Liberopoulos, E. N.; Moutzouri, E.; Rizos, C. V.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) StudyAthyros, V. G.; Mikhailidis, D. P.; Liberopoulos, E. N.; Kakafika, A. I.; Karagiannis, A.; Papageorgiou, A. A.; Tziomalos, K.; Ganotakis, E. S.; Elisaf, M. S.24-Nov-2015-
THE EFFECTS OF COMBINING ROSUVASTATIN WITH SARTANS OF DIFFERENT PPAR gamma ACTIVATING CAPACITY ON LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2)Rizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Effects of eprosartan on serum metabolic parameters in patients with essential hypertensionRizos, E. C.; Spyrou, A.; Liberopoulos, E. N.; Papavasiliou, E. C.; Saougos, V.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of hormonal treatment on lipids in patients with cancerFilippatos, T. D.; Liberopoulos, E. N.; Pavlidis, N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Effects of orlistat and fenofibrate combination on LDL phenotype in overweight and obese patients with metabolic syndrome. The fenorli studyFilippatos, T. D.; Kiortsis, D. N.; Gazi, I.; Liberopoulos, E. N.; Georgoula, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndromeFilippatos, T. D.; Liberopoulos, E. N.; Kostapanos, M.; Gazi, I. F.; Papavasiliou, E. C.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Showing results 34 to 53 of 117 < previous   next >